Cornea tolerates prolonged exposure to viscoadaptive

March 1, 2004

Eugene, OR-Prolonged presence of 2.3% sodium hyaluronate (Healon5, Pfizer) in the eye in association with its use for anterior chamber stabilization following trabeculectomy appears to be well-tolerated by the cornea, according to results of a study undertaken by Richard S. Hoffman, MD, and colleagues at the Oregon Eye Institute, Eugene.